Mease K, Kimzey A, Lansita J. 2017. Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design. Curr Opin Toxicol (4:1–15).
View Abstract
Publication: Manuscripts
Doepker D , Tyndall K, Lane R, Wikoff D, Thompson C, Harvey S, Schmitt D . 2017. A proposed ADI for nitrate. Poster presented at Society of Toxicology Annual Meeting, March 16, Baltimore, MD.
View Abstract
Publication: Abstracts and Presentations
Borghoff SJ, Ring C , Banton MI, Leavens TL. 2017. Ethyl tertiary butyl ether (ETBE) and tertiary butyl alcohol (TBA) physiologically based pharmacokinetic (PBPK) model in rats: Contribution of binding to ?2u-globulin and non-linear kinetics to kidney and liver responses in rats. Poster presented at Society of Toxicology Annual Meeting, March 16, Baltimore, MD.
View Abstract
Publication: Abstracts and Presentations
Thompson C, Rager J, Suh M, Proctor D, Haws L, Harris M. Mechanistic support for nonlinear risk assessment of rat oral cavity tumors induced by exposure to Cr(VI) in drinking water. Poster presented at Society of Toxicology Annual Meeting. March 15, Baltimore, MD, 2017.
View Abstract
Publication: Abstracts and Presentations
/ Topics: chromium , Cr(VI) MOA Study
Chappell G, Welsh B, Harvey S, Harris M, Wikoff D . Validation and application of a text mining tool in the identification and categorization of mechanistic data: A case study in improving problem formulation of carcinogenicity assessments. Poster presented at Society of Toxicology 56th Annual Meeting, Baltimore, MD, March 2017.
View Abstract
Publication: Abstracts and Presentations
/ Topics: carcinogens , risk assessment
Proctor DM, Suh M , Dunsmore D, Verwiel A , Casteel S. 2017. Bioaccessibility and relative oral bioavailability of cobalt and nickel from metal alloys in soil and dust. Poster presented at Society of Toxicology Annual Meeting, March 15, Baltimore, MD.
View Abstract
Publication: Abstracts and Presentations
Kirman CR, Proctor D, Suh M, Haws L, Harris M, Thompson C , Hays S. Using physiologically based pharmacokinetic modeling to address potentially sensitive subpopulations exposed to hexavalent chromium. Poster presented at Society of Toxicology Annual Meeting, Baltimore, MD, March 2017.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Chrome VI , Hexavalent Chromium
Rager JE, Thompson CM, Ring C , Fry RC, Harris MA. Integration of transcriptomics and high-throughput screening predictions with robust in vivo data to inform hexavalent chromium mode of action. Poster presented at Society of Toxicology 56th Annual Meeting, Baltimore, MD, March 2017.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Chrome VI , Hexavalent Chromium
Thompson C , Kirman C, Suh M, Proctor D, Haws L, Harris M, Hays S. Risk assessment of oral exposure to Cr(VI): Integration of mode of action, pharmacokinetics, and dose-response modeling. Poster presented at Society of Toxicology 56th Annual Meeting, Baltimore, MD, March 2017.
View Abstract